Document Detail


Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency.
MedLine Citation:
PMID:  19804466     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Pancreatic enzyme supplements are standard therapy for fat malabsorption in patients with exocrine pancreatic insufficiency. The FDA determined that published data are insufficient to support the efficacy and safety of these agents. AIM: To determine if pancreatic enzyme supplements are: (i) superior to placebo for treating fat malabsorption and (ii) superior to other supplements based on randomized cross-over trials. METHODS: A computer-assisted search of MEDLINE and EMBASE was performed to identify relevant studies. Data extraction on study design, improvement in coefficient of fat absorption, diarrhoea and adverse events using prespecified forms. RESULTS: A total of 12 manuscripts met inclusion criteria. Most studies (10/12) compared pancreatic enzyme supplements that used different delivery systems, while using similar quantities of enzymes. These studies found no consistent difference in fat malabsorption or gastrointestinal symptoms between different active treatments. Two small placebo-controlled trials (n = 65 patients) demonstrate that pancreatic enzyme supplements are superior to placebo for fat absorption. Data are inadequate to determine if pancreatic enzyme supplements lead to weight gain or improvement in diarrhoea. CONCLUSIONS: Based on data from randomized cross-over trials, pancreatic enzyme supplements appear to improve fat malabsorption. No specific branded product or specific delivery system is superior for treatment of fat malabsorption in patients with exocrine pancreatic insufficiency.
Authors:
J R Taylor; T B Gardner; A K Waljee; M J Dimagno; P S Schoenfeld
Related Documents :
19868096 - The absorption of fat in partially, and in completely depancreatized dogs.
7199936 - The effect of dietary raw and autoclaved soya-bean protein fractions on growth, pancrea...
12235656 - Effects of dietary fat on virus-induced pancreatic carcinogenesis in guinea fowl.
20354346 - Hypolipidemic effect of pleurotus eryngii extract in fat-loaded mice.
6491676 - Effects of chronic (dietary) choline availability on the transport of choline across th...
2626986 - Serum total cholesterol and hdl-cholesterol levels as associated with copper and zinc i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  31     ISSN:  1365-2036     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-16     Completed Date:  2010-05-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  57-72     Citation Subset:  IM    
Affiliation:
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MI 48105, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cross-Over Studies
Cystic Fibrosis / complications,  drug therapy*,  enzymology
Diarrhea / drug therapy*,  enzymology
Enzymes / therapeutic use*
Exocrine Pancreatic Insufficiency / drug therapy*,  enzymology,  etiology
Humans
Placebos / therapeutic use
Randomized Controlled Trials as Topic
Chemical
Reg. No./Substance:
0/Enzymes; 0/Placebos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The alcohol industry and public interest science.
Next Document:  Acute pyelonephritis with renal abscesses and acute renal failure after salmonella infection.